{"disease":{"id":"schizoaffective-disorder-depressive-type","name":"schizoaffective disorder depressive type"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05934474","title":"Biocollection on Peripheral Inflammation","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT04203056","title":"Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":15,"lead_sponsor_name":"University of California, Los Angeles","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}